Menu

2020年绥美凯最新价格

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

What is the latest price of Suimeikai (Duotie Abalamid Tablets, Inbec) in 2020? Many patients have asked this question recently. Let’s take a look at it together. Trimax (Dolutegravir Tablets, Inbec) is a compound preparation. Each tablet contains dolutegravir sodium (calculated as dolutegravir) 50 mg, abacavir sulfate (calculated as abacavir) 600 mg and lamivudine 300 mg. Trimax (Dolutegravir Tablets, Inbec) is suitable for the treatment of adults infected with human immunodeficiency virus (HIV) and adolescents over 12 years old (with a weight of at least 40kg).

On January 20, 2018, GlaxoSmithKline China (GSK China) announced that its single-tablet compound preparation Suimeike (Dolutea, Inbec) (chemical name: Dolutea, Inbec) was officially launched in mainland China.

Suimeikai (Domitabalamid Tablets, Inbec) is currently priced at 2,880$/month in the Chinese market. If patients cannot afford the domestic price of Suimeike (Dolutea, Inbec), they can choose to buy the original drug Suimeike (Dolutea, Inbec) which is available in India. The price is relatively cheap. Suimeike (Dolutea, Inbec) produced by the Indian company Emcure has a box of 30 tablets and sells for about RMB 1,000. It is the most cost-effective version of Suimeike (Inbec) in the world. 

There are generally two most reliable ways to buy genuine Indian Suimeike (Dolutea Paramid Tablets, Inbec): First, if you are able, the patient himself goes to a well-known hospital in India and goes to the corresponding pharmacy to get the medicine according to the prescription issued by the attending doctor. This can ensure formal channels for obtaining medicines from the source. The second way is to find a professional overseas medical service organization in China (such as Medical Travel). Medical Travel has cooperation with foreign pharmaceutical companies and can help you buy genuine Indian Suimeike (Dolute Abalami Tablets, Inbec).

In 2016, GSK launched the integrase DTG (Inbec) in China. This therapeutic agent has the advantages of small drug dosage, resistance to drug resistance, and low probability of drug side effects. This time, Inbec (Inbec) uses DTG, an integrase inhibitor, as the core drug, and combines it with abacavir and lamivudine as a treatment plan. It is made into a single-tablet treatment and promoted, making the core drug a great progress in HAART treatment.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。